Amy Wagers
Content tagged with Amy Wagers
Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Muscular dystrophy collaboration aims to correct muscle stem cell DNA
News
HSCI research receives support from Sarepta to advance in-vivo genome editing toward prospective therapy HSCI researchers led by Amy Wagers, Ph.D. are embarking on a major study of Duchenne muscular dystrophy (DMD). The project aims to use in vivo genome...
Editing genes at the source
News
Breakthrough research shows that stem cell genes can be edited in living systems New research led by HSCI Executive Committee member Amy Wagers has demonstrated that gene-editing machinery can be delivered straight to stem cells where they live, rather...
HSCI scientists receive “High-Risk, High-Reward” awards
News
Amy Wagers, Richard Lee, and Norbert Perrimon receive National Institutes of Health Director’s awards for innovative research Three scientists at the Harvard Stem Cell Institute (HSCI) have been honored by the National Institutes of Health (NIH) Director...
A case study for casual collaboration
News
Annual symposium drives innovative research between CIRM-HSCI scientists The organizers of this year’s Harvard Stem Cell Institute/ California Institute for Regenerative Medicine Junior Faculty Symposium knew that it was time to rebrand. The 40 regulars...
Functioning of aged brains and muscles in mice made younger
News
Lee Rubin, PhD, and Amy Wagers, PhD, (below) of the Harvard Stem Cell Institute provide more evidence that a protein known as GDF11 reverses signs of aging in mice. (Credit: B.D. Colen/Harvard University) Harvard stem cell researchers advance...
New research implicates immune system cells in muscle healing
News
Harvard stem cell scientists have found that cells known primarily for tempering immune response also exist in injured muscle tissue, an unexpected role for regulatory T cells. Regulatory T cells, or Tregs for short, accumulate in the skeletal muscles of...
Age-related effects of MS may prove reversible
News
Harvard stem cell researchers and scientists at the University of Cambridge in the United Kingdom have found that the age-related degeneration in conditions such as multiple sclerosis (MS) may be reversible. The researchers, co-led by Associate Professor...
Cross-country collaboration leads to new model of leukemia development
News
Eight years ago, two former Stanford University postdoctoral fellows, one of them still in California and the other at the Harvard Stem Cell Institute (HSCI) in Cambridge, began exchanging theories about why patients with leukemia stop producing healthy...